Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy

American Journal of Roentgenology

Volumn 197, Issue 6, 2011, Pages

  Bronstein, Yulia ^a   Ng, Chaan S ^a   Hwu, Patrick ^a   Hwu, Wen Jen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anti CTLA 4 antibodies; Immune related adverse events; Ipilimumab; Metastatic melanoma; Radiologic findings; Tremelimumab

Indexed keywords

ANTINUCLEAR ANTIBODY; CREATINE KINASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; FLUORODEOXYGLUCOSE F 18; IPILIMUMAB; RHEUMATOID FACTOR; TICILIMUMAB;

ADULT; AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; ASEPTIC MENINGITIS; CANCER CONTROL; CANCER GROWTH; CLINICAL FEATURE; COLITIS; COLON DILATATION; COLON DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DRUG RESPONSE; EDEMA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; FASCIITIS; FEMALE; GRAVES DISEASE; HIP PAIN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOPHYSITIS; HYPOTHYROIDISM; IMAGE ANALYSIS; IMMUNOTOXICITY; JOINT EFFUSION; KNEE PAIN; LEUKODERMA; LOW DRUG DOSE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS POTENTIAL; MYALGIA; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PRURITUS; RADIODIAGNOSIS; RETROPERITONEAL FAT; RETROSPECTIVE STUDY; SACROILIITIS; SARCOIDOSIS; SIDE EFFECT; SUBCUTANEOUS FAT; SYNOVITIS; THYROIDITIS; TOXIC MEGACOLON; UVEITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CTLA-4 ANTIGEN; FEMALE; HUMANS; IMMUNOTHERAPY; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 82455194995     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6198     Document Type: Article

References (23)

1. Kaehler KC, Egberts F, Lorigan P, Hauschild A. Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient. Melanoma Res 2009; 19:333-334
2. Weber J. Ipilimumab: controversies in its development, utility and autoimmune adverse events. Cancer Immunol Immunother 2009; 58:823-830
3. Kaehler KC, Piel S, Livingstone E, Schilling B, Hauschild A, Schadendorf D. Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management. Semin Oncol 2010; 37:485-498
4. Camacho LH, Antonia S, Sosman J, et al. Phase I/II trial of tremelimumab in patients with metastatic melanoma. J Clin Oncol 2009; 27:1075-1081
5. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228-247
6. Wallis N, Bulanhagui CA, Dorazio PC, et al. Safety of tremelimumab (CP-675,206) in patients (pts) with advanced cancer (abstr). J Clin Oncol 2008; 26(suppl):142S
7. Oble DA, et al. Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis. Am J Surg Pathol 2008; 32:1130-1137
8. Blansfield JA, Beck KE, Tran K, et al. Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother 2005; 28:593-598 (Pubitemid 41533093)
9. Carpenter KJ, Murtagh RD, Lilienfeld H, Weber J, Murtagh FR. Ipilimumab-induced hypophysitis: MR imaging findings. AJNR 2009; 30:1751-1753
10. Yang JC, Hughes M, Kammula U, et al. Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother 2007; 30:825-830 (Pubitemid 350295361)
11. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-723
12. Fadel F, El Karoui K, Knebelmann B. Anti-CTLA4 antibody-induced lupus nephritis. N Engl J Med 2009; 361:211-212
13. Eckert A, Schoeffler A, Dalle S, Phan A, Kiakouama L, Thomas L. Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient. Dermatology 2009; 218:69-70
14. Daïen CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 2009; 48:883-886
15. van der Stoep D, Braunstahl GJ, van Zeben J, Wouters J. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge. J Rheumatol 2009; 36:2847-2848
16. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 2005; 141:865-868 (Pubitemid 41058068)
17. Ubina-Aznar E, Fernández-Moreno N, Rivera-Irigoín R, et al. Pulmonary sarcoidosis associated with pegylated interferon in the treatment of chronic hepatitis C [in Spanish]. Gastroenterol Hepatol 2005; 28:450-452 (Pubitemid 41530539)
18. Vordenbäumen S, Neuen-Jacob E, Richter J, Schneider M. Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFalpha and rituximab. Clin Rheumatol 2010; 29:555-558
19. Hunter G, Voll C, Robinson CA. Autoimmune inflammatory myopathy after treatment with ipilimumab. Can J Neurol Sci 2009; 36:518-520
20. Surabhi VR, Menias C, Prasad SR, Patel AH, Nagar A, Dalrymple NC. Neoplastic and nonneoplastic proliferative disorders of the perirenal space: cross-sectional imaging findings. RadioGraphics 2008; 28:1005-1017
21. Alberti C. Retroperitoneal fibroses: aetiopathogenesis and taxonomic assessment. Eur Rev Med Pharmacol Sci 2007; 11:375-382 (Pubitemid 351242499)
22. Wolchok JD, Hoos A, O'Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res 2009; 15:7412-7420
23. Downey SG, Klapper JA, Smith FO, et al. Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade. Clin Cancer Res 2007; 13:6681-6688 (Pubitemid 350206804)